Prime Medicine, Inc.
PRME
$4.04
$0.308.02%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 144.26M | 190.44M | 175.53M | 162.87M | 210.72M |
| Total Receivables | 17.00K | -- | 55.00M | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 2.95M | 6.78M | 6.01M | 4.20M | 4.20M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 16.54M | 14.67M | 9.54M | 3.74M | 2.73M |
| Total Current Assets | 163.77M | 211.89M | 246.07M | 170.80M | 217.65M |
|
|
|||||
| Total Current Assets | 163.77M | 211.89M | 246.07M | 170.80M | 217.65M |
| Net Property, Plant & Equipment | 150.34M | 71.56M | 72.65M | 75.41M | 79.45M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 14.06M | 14.06M | 14.06M | 13.50M | 14.28M |
| Total Assets | 328.16M | 297.51M | 332.78M | 259.71M | 311.38M |
|
|
|||||
| Total Accounts Payable | 10.03M | 11.35M | 5.43M | 4.64M | 10.08M |
| Total Accrued Expenses | 6.16M | 11.82M | 17.28M | 8.82M | 4.20M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 6.86M | 3.61M | 4.48M | 5.22M | 6.75M |
| Total Finance Division Other Current Liabilities | 11.25M | 11.18M | 10.68M | 2.07M | 3.41M |
| Total Other Current Liabilities | 11.25M | 11.18M | 10.68M | 2.07M | 3.41M |
| Total Current Liabilities | 34.29M | 37.96M | 37.88M | 20.75M | 24.44M |
|
|
|||||
| Total Current Liabilities | 34.29M | 37.96M | 37.88M | 20.75M | 24.44M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 114.29M | 37.18M | 36.76M | 36.37M | 37.04M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 72.66M | 69.22M | 68.64M | 6.00M | 6.13M |
| Total Liabilities | 221.24M | 144.36M | 143.28M | 63.12M | 67.62M |
|
|
|||||
| Common Stock & APIC | 846.04M | 840.36M | 834.42M | 789.08M | 780.95M |
| Retained Earnings | -739.10M | -687.21M | -644.94M | -592.42M | -537.09M |
| Treasury Stock & Other | -15.00K | 1.00K | 21.00K | -71.00K | -95.00K |
| Total Common Equity | 106.92M | 153.15M | 189.50M | 196.59M | 243.77M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 106.92M | 153.15M | 189.50M | 196.59M | 243.77M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 106.92M | 153.15M | 189.50M | 196.59M | 243.77M |
|
|
|||||